Selinexor in Advanced Liposarcoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

January 4, 2016

Primary Completion Date

October 28, 2020

Study Completion Date

October 26, 2021

Conditions
Dedifferentiated Liposarcoma
Interventions
DRUG

Selinexor

Selinexor 60mg

DRUG

Placebo

Trial Locations (71)

1090

UZ Brussel, Brussels

1200

UCL Saint-Luc, Brussels

9000

UZ Gent, Ghent

10032

Columbia University Medical Center, New York

10060

Candiolo Cancer Institute, Candiolo

10065

Memorial Sloan Kettering Cancer Center, New York

11042

Northwell Health Physicians Partners, New York

13125

Helios Hospital Berlin-Buch, Berlin

13385

Timone University Hospital, Marseille

15232

University of Pittsburgh Medical Center (UPMC), Pittsburgh

19106

University of Pennsylvania, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

20133

Istituto Nazionale dei Tumori, Milan, Milan

21231

Johns Hopkins, Baltimore

27710

Duke Institute of Cancer, Durham

28040

Hospital Universitario Clínico San Carlos, Madrid

31059

Institut Claudius Regaud, Toulouse

32224

Mayo Clinic, Jacksonville

33076

Institut Bergonie, Bordeaux

34298

Institut Régional du Cancer de Montpellier (ICM), Montpellier

37232

Vanderbilt, Nashville

41013

"Germans Trias Pujol University Hospital", Badalona

Hospital Universitario Virgen Del Rocio, Seville

46026

Hospital La Fe Valencia, Valencia

48109

University of Michigan, Ann Arbor

52621

Sheba Medical Center, Ramat Gan

55905

Mayo Clinic Rochester, Rochester

59020

Oscar Lambret Center, Lille

60611

Northwestern Memorial Hospital, Chicago

63110

Washington University School of Medicine, St Louis

64239

Tel Aviv Sourasky Medical, Tel Aviv

68167

University Hospital Mannheim, Mannheim

69120

National Center for Tumor Diseases, Univeristy Hospital Heidelberg, Heidelberg

75248

Institut Curie, Paris

77030

MD Anderson, Houston

80202

University of Colorado-Denver, Denver

81675

Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie Klinikum rechts der Isar der TU Muenchen, München

84101

Soroka University Medical Center, Beersheba

90048

Cedars-Sinai Medical Center, Los Angeles

90095

University of California, Los Angeles, Los Angeles

90127

U.O.C. Oncologia Medica Oncology Department, Palermo

90403

Sarcoma Oncology Center, Santa Monica

91120

Hadassah Medical Center, Jerusalem

94110

Institut Gustave Roussy, Villejuif

94305

Stanford University, Stanford

96373

Centre Leon Berard, Lyon

97239

Oregon Health and Science, Portland

98109

Fred Hutchinson Cancer Research Center, Seattle

4941492

Rabin Medical Center, Petah Tikva

7030000

Assaf Harofe Medical Center, Ẕerifin

06520-8032

Yale Cancer Center, New Haven

02114

Massachusetts General Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

43210-1240

James Cancer Center, Ohio State University, Columbus

T6G1Z2

Cross Cancer Center - Alberta Health Services, Edmonton

Unknown

The Ottawa Hospital Cancer, Ottawa

M5G 2M9

Princess Margaret Hospital, Toronto

H4A3J1

McGill University, Montreal

06789

CLCC Antoine Lacassagne, Nice

01307

Technische Universitaet Dresden Med. Fakultaet Carl Gustav Carus Med. Klinik u. Poliklinik I, Dresden

00128

Policlinico Universitario Campus Biomedico, Roma

08035

Vall d´hebron University Hospital, Barcelona

08041

Hospital Sant Pau Barcelona, Barcelona

08908

Hospital ICO Bellvitge, Barcelona

413 45

Sahlgrenska Universitetssjukhuset, Gothenburg

221 85

Skane University Hospital, Lund

171 76

Onkologiska Kliniken, Stockholm

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

NW1 2BU

University College London Hospitals, London

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

M20 4BX

The Christie, Manchester

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY